Search
+
    SEARCHED FOR:

    ASTRAZENECA COVID VACCINE

    ‘Doctors knew Covid vaccine’s side-effects killed my daughter. But they didn’t tell us’

    Dr Snehal Lunawat was the first case in which the AEFI committee accepted there was a direct correlation between vaccination and death. Many of the petitioners, like her father Dilip, have questioned why information about the side-effects wasn’t made public earlier.

    Covaxin side effects: What are the symptoms reported in adverse event cases? Should you worry?

    Covaxin side effects: A recent study highlighted adverse events post-Bharat Biotech's Covaxin vaccinations. Led by Sankha Shubhra Chakrabarti, it noted higher risk in female adolescents and those with allergies. Of 1,024 participants, 47.9% adolescents and 42.6% adults reported viral infections. Common AESIs included skin disorders, menstrual abnormalities in females, and serious cases like stroke. Monitoring vaccinated individuals, especially those with prior Covid history, is crucial.

    Good shot, bad shot: What you need to know about Covishield issue

    Covishield Side Effects: Controversies surrounding vaccine side-effects persist despite Covid-19 waning. Covishield, developed by AstraZeneca and Oxford University, faces scrutiny in India following reports of rare side effects. Legal battles and demands for compensation have emerged as families of alleged victims seek justice. Experts stress the importance of understanding risks versus benefits in vaccine administration.

    Clot in blood vessels occurs in rare cases with certain vaccines: Medical Expert amid reports over AstraZeneca

    Dr. Rajeev Jayadevan, Co-Chairman of the National Indian Medical Association (IMA) Covid Task Force in Kerala, explains that Thrombosis Thrombocytopenia Syndrome (TTS), involving blood clots in rare cases, has been associated with certain vaccines, including adenovirus vector vaccines like Covishield. Despite the rarity, such events have been highlighted in reports, amidst recent admission by AstraZeneca regarding TTS risks. The WHO has also issued guidance on managing TTS cases following COVID-19 vaccination.

    Covishield side effects: Doctors' group urges govt to review all Covid vaccines

    AstraZeneca acknowledges Covid vaccine risk. Doctors express Covishield concerns. Emphasis on active surveillance. Urgency for investigation, fast track courts, compensation for vaccine injuries.

    BJP has put lives of its countrymen at risk: SP chief Akhilesh Yadav on global withdrawal of Covishield

    Akhilesh Yadav slams BJP for risking lives with AstraZeneca's global Covishield withdrawal due to excess supply. How will dangerous vaccine return from recipients? Rare side effect TTS disclosed.

    • AstraZeneca to withdraw Covid vaccine globally as demand declines; faces legal challenges over side effects

      Astrazeneca Vaccine: AstraZeneca has announced the worldwide withdrawal of its COVID-19 vaccine, Vaxzevria, citing a surplus of updated vaccines amid the pandemic. The company has also faced legal challenges over reported side effects, including blood clots. Families of affected individuals are pursuing legal action, seeking compensation and holding multiple parties accountable for their losses.

      Disclosed all information on Covishield’s side effects in 2021, says SII

      The Serum Institute of India (SII) has stated that the safety of vaccines remains "paramount" and that all information about the side effects of its Covishield vaccine against Covid-19 was disclosed in its packaging insert in 2021. The statement comes after a group of parents whose children died during the pandemic filed a case against the company. SII manufactured and supplied the vaccine under license from AstraZeneca, which admitted in court that the vaccine could cause a rare side effect.

      Covishield deaths could be more than estimates: Parents

      SII discloses TTS side-effects. Venugopalan Govindan raises Covishield concerns. Parents plan case against SII. AstraZeneca withdraws VaxAstraZeneca due to mutant variant strains.

      Covishield Side Effects: What's TTS syndrome, symptoms, and danger signs you shouldn't ignore

      Covishield TTS: AstraZeneca has acknowledged the potential TTS side effects from its COVID-19 vaccine Covishield, used widely in India. TTS, Thrombosis with Thrombocytopenia Syndrome, is rare but serious, marked by blood clots and low platelet levels. Symptoms include headaches, blurred vision, and chest pain. Dr. Jayadevan emphasizes awareness, stressing early treatment for effective management. AstraZeneca's admission follows reports of TTS linked to adenovirus vector vaccines.

      Heart-related tests be made free for those who took Covid vaccine, says Akhilesh Yadav

      Akhilesh Yadav criticizes Covid vaccine, demands free heart tests. AstraZeneca's Vaxzevria linked to blood clot side effect. Criticizes BJP leaders, emphasizes public rights, inflation reduction, democracy preservation, youth future, 2024 Lok Sabha elections.

      AstraZeneca vaccine side effect rare, occurs within a month of getting jab: Ex-ICMR Scientist

      R Ganga Ketkar allays fears of Covid vaccine side effects, focusing on TTS. Covishield's low TTS risk 5-30 days post-vaccination. ICMR ensures post marketing surveillance. AstraZeneca dispels myths, promoting childhood vaccination.

      Covishield Vaccine Case: AstraZeneca expresses 'sympathy' for those who lost loved ones

      Covishield Vaccine Row: Following AstraZeneca's acknowledgment of a rare side effect associated with its COVID-19 vaccine, known as Covishield in India, the UK pharmaceutical giant extended sympathy to those impacted. Reaffirming its dedication to patient safety amidst concerns about potential rare side effects, AstraZeneca emphasised the vaccine's overall safety profile. The company underscored the stringent standards of regulatory authorities to ensure the safe use of medicines, including vaccines. AstraZeneca highlighted the extensive clinical trial data and real-world evidence consistently supporting the safety and efficacy of the vaccine.

      Amid Covishield row, what WHO says on side-effects from Covid vaccine? Should you be worried?

      Recent revelations by pharmaceutical company AstraZeneca have brought Covid vaccines back into the spotlight, with acknowledgment that its AstraZeneca-Oxford vaccine can, in very rare instances, lead to Thrombosis Thrombocytopenia Syndrome (TTS)," a condition involving the formation of blood clots in blood vessels. Despite these rare occurrences, the pharmaceutical firm maintains that extensive clinical trial data and real-world evidence consistently support the safety and effectiveness of the vaccine.

      Concerns raised over Covishield vaccine safety in India's apex court

      A plea has been filed seeking setting up of an expert medical panel to study and assess the possible risk factors associated with the Astrazeneca's Covishield vaccine, which was one of two vaccines administered in India against Covid-19. Advocate Vishal Tiwari in his fresh application said that AstraZeneca had accepted a link between the vaccine and Thrombosis with Thrombocytopenia Syndrome (TTS).

      BJP put lives at stake for extorting political donations from vaccine manufacturer: Akhilesh Yadav

      Amid a controversy surrounding the Covishield vaccine's alleged side effects, Samajwadi Party chief Akhilesh Yadav accused the BJP of risking lives for political donations from the vaccine manufacturer. He called for a high-level judicial probe, stating that allowing such medicines is akin to a conspiracy to commit murder. AstraZeneca, the manufacturer of Covishield, has admitted to a rare blood clot-related side effect in its COVID-19 vaccine. Akhilesh Yadav criticised the BJP for allegedly putting public lives at risk for political gain and called for a thorough investigation into the matter. The controversy has sparked concerns about the safety and efficacy of the vaccine, with opposition leaders demanding accountability and transparency in vaccine distribution.

      Covishield Vaccine: Bereaved parents to take Serum Institute of India to Court following AstraZeneca's rare side effect admission

      Covishield Vaccine Case: The parents of a woman allegedly deceased after receiving the Covishield vaccine plan to file a case against the Serum Institute of India (SII). This decision follows AstraZeneca's acknowledgment in court that their Covid shot can cause a rare side effect, providing hope for the parents in seeking justice. AstraZeneca faces a class-action lawsuit over allegations that its vaccine, developed with the University of Oxford, led to deaths and serious injuries, including thrombosis with thrombocytopenia syndrome (TTS), characterized by blood clots and low platelet count.

      Centre should urgently address alleged side-effects of Covishield, says Delhi health minister

      UK-headquartered pharmaceutical giant AstraZeneca has admitted that in "very rare cases", its COVID-19 vaccine can cause a blood clot-related side-effect but the causal link is unknown, according to court papers being quoted in the UK media.

      AstraZeneca acknowledges its covid vaccine, Covishield, can lead to rare blood clot side effects; Here's what we know

      Covishield Covid Vaccine: The Covishield COVID-19 vaccine, developed by AstraZeneca in partnership with the University of Oxford, has been acknowledged for its potential to induce a rare side effect known as Thrombosis with Thrombocytopenia Syndrome (TTS). This acknowledgment coincides with a legal case alleging severe adverse effects, including fatalities, linked to the vaccine. Kate, the spouse of one affected individual, calls for an apology and just compensation after a three-year ordeal.

      Load More
    The Economic Times
    BACK TO TOP
    Advertisement